221 related articles for article (PubMed ID: 34992377)
1. Clinical Features, Cancer Biology, Transplant Approach and Other Integrated Management Strategies for Wiskott-Aldrich Syndrome.
Hosahalli Vasanna S; Pereda MA; Dalal J
J Multidiscip Healthc; 2021; 14():3497-3512. PubMed ID: 34992377
[TBL] [Abstract][Full Text] [Related]
2. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
4. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
Coppola E; Giardino G; Abate M; Tambaro FP; Bifano D; Toriello E; De Rosa A; Cillo F; Pignata C; Cirillo E
Front Immunol; 2023; 14():1229674. PubMed ID: 37781361
[TBL] [Abstract][Full Text] [Related]
5. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
Kindwall-Keller TL; Ballen KK
Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
[TBL] [Abstract][Full Text] [Related]
6. [Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome].
Wietstruck P MA; Zúñiga C P; Talesnik G E; Méndez R C; Barriga C F
Rev Med Chil; 2007 Jul; 135(7):917-23. PubMed ID: 17914550
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM
Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097
[TBL] [Abstract][Full Text] [Related]
9. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
[TBL] [Abstract][Full Text] [Related]
10. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
11. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning.
Sharma A; Rastogi N; Kapoor R; Chatterjee G; Yadav SP
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e230-e233. PubMed ID: 32459721
[TBL] [Abstract][Full Text] [Related]
12. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
[TBL] [Abstract][Full Text] [Related]
13. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in Wiskott-Aldrich syndrome and successfully treated with umbilical cord blood transplantation.
Zhu X; Tang B; Zheng C; Liu H; Song K; Sun Z
Blood Cells Mol Dis; 2014 Dec; 53(4):283-5. PubMed ID: 24824128
[TBL] [Abstract][Full Text] [Related]
15. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments.
Buchbinder D; Nugent DJ; Fillipovich AH
Appl Clin Genet; 2014; 7():55-66. PubMed ID: 24817816
[TBL] [Abstract][Full Text] [Related]
16. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
17. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
Front Immunol; 2018; 9():2554. PubMed ID: 30450104
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of X-linked polymorphic loci as gene markers to track X allele and chimerism in a post-allogeneic peripheral blood stem cell transplant patient with Wiskott-Aldrich syndrome.
Sasanakul W; Hongeng S; Chuansumrit A; Chaiyaratana W; Pakakasama S; Hathirat P
J Med Assoc Thai; 2001 Mar; 84(3):379-84. PubMed ID: 11460939
[TBL] [Abstract][Full Text] [Related]
19. Un-manipulated Haploidentical Transplant in Wiskott-Aldrich Syndrome.
John MJ; Philip CC; Mathew A; Williams A; Kakkar N
Indian Pediatr; 2017 Apr; 54(4):327-328. PubMed ID: 28474594
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome.
Yue Y; Shi X; Song Z; Qin J; Li J; Feng S; Liu R
Pediatr Blood Cancer; 2018 Aug; 65(8):e27092. PubMed ID: 29745014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]